Literature DB >> 8197148

Posttranscriptional mRNA processing as a mechanism for regulation of human A1 adenosine receptor expression.

H Ren1, G L Stiles.   

Abstract

The human A1 adenosine receptor gene contains six exons with exons 1, 2, 3, 4, and part of 5 representing 5' untranslated regions. Reverse transcription-PCR with exon-specific primers showed two distinct transcripts containing either exons 3, 5, and 6 or exons 4, 5, and 6, with exons 3 and 4 being mutually exclusive. No mature mRNAs containing exons 1 and 2 have been detected. All human tissues that express any A1 receptors contain mRNA with exons 4, 5, and 6. Tissues which express high levels of A1 receptors contain mRNA with exons 3, 5, and 6. Exon 4 contains two upstream ATG codons whereas exon 3 contains none. COS cells transfected with expression vectors containing exon 4 (exons 1-6, 3-6, or Ex4-6) express much lower levels of A1 receptors than vectors without exon 4 (exons 3, 5, and 6). Mutation of upstream ATG codons in exon 4 leads to 3- to 7-fold increased A1 receptor expression, up to the level seen with the construct containing exons 3, 5, and 6. Thus, in human tissues "basal" levels of A1 receptors can be expressed by use of mRNA containing exons 4, 5, and 6, but when high levels are needed, alternative transcripts with exons 3, 5, and 6 are produced.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8197148      PMCID: PMC43889          DOI: 10.1073/pnas.91.11.4864

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

2.  Translational regulation of complement protein C2 expression by differential utilization of the 5'-untranslated region of mRNA.

Authors:  T Horiuchi; K J Macon; V J Kidd; J E Volanakis
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

3.  Multiple upstream AUG codons mediate translational control of GCN4.

Authors:  P P Mueller; A G Hinnebusch
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

4.  HMG CoA reductase: a negatively regulated gene with unusual promoter and 5' untranslated regions.

Authors:  G A Reynolds; S K Basu; T F Osborne; D J Chin; G Gil; M S Brown; J L Goldstein; K L Luskey
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

Review 5.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

6.  Translational activation of the lck proto-oncogene.

Authors:  J D Marth; R W Overell; K E Meier; E G Krebs; R M Perlmutter
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

7.  Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing.

Authors:  H Ren; G L Stiles
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

8.  Mutations in the structural genes for eukaryotic initiation factors 2 alpha and 2 beta of Saccharomyces cerevisiae disrupt translational control of GCN4 mRNA.

Authors:  N P Williams; A G Hinnebusch; T F Donahue
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Sequence of full length cDNA for human S-adenosylhomocysteine hydrolase.

Authors:  D E Coulter-Karis; M S Hershfield
Journal:  Ann Hum Genet       Date:  1989-05       Impact factor: 1.670

10.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

View more
  15 in total

1.  Effect of G protein heterotrimer composition on coupling of neurotransmitter receptors to N-type Ca(2+) channel modulation in sympathetic neurons.

Authors:  S W Jeong; S R Ikeda
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Constraints on reinitiation of translation in mammals.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

3.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

Review 4.  Interpreting cDNA sequences: some insights from studies on translation.

Authors:  M Kozak
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

5.  Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression.

Authors:  K Biber; K N Klotz; M Berger; P J Gebicke-Härter; D van Calker
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

6.  Structure and alternative promoters of the mouse glutamic acid decarboxylase 67 gene.

Authors:  Y Yanagawa; T Kobayashi; T Kamei; K Ishii; M Nishijima; A Takaku; S Tamura
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

Review 7.  A1 Adenosine Receptor Activation Modulates Central Nervous System Development and Repair.

Authors:  Shirin Kashfi; Kamran Ghaedi; Hossein Baharvand; Mohammad Hossein Nasr-Esfahani; Mohammad Javan
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

8.  The human A1 adenosine receptor: ligand binding properties, sites of somatic expression and chromosomal localization.

Authors:  S A Rivkees; M E Lasbury; G S Stiles; O Henegariu; C Curtis; G Vance
Journal:  Endocrine       Date:  1995-09       Impact factor: 3.633

Review 9.  Mechanisms of induction of adenosine receptor genes and its functional significance.

Authors:  Cynthia St Hilaire; Shannon H Carroll; Hongjie Chen; Katya Ravid
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

10.  Identification of the sensory neuron specific regulatory region for the mouse gene encoding the voltage-gated sodium channel NaV1.8.

Authors:  Henry L Puhl; Stephen R Ikeda
Journal:  J Neurochem       Date:  2008-05-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.